Tokyo Tape
Sign in
← RaQualia Pharma

Quarterly report · Q3

4579.TEDINET S100PL8D
Period2022-01-01 → 2022-09-30
Filed2022-11-11
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 46
MetricValuePeriodScopeSource row
Operating income¥501m2022-01-01 → 2022-09-30Cons.Operating income
Operating income¥107m2021-01-01 → 2021-09-30Cons.Operating income
Ordinary income¥676m2022-01-01 → 2022-09-30Cons.Ordinary income
Ordinary income¥864m2021-01-01 → 2021-12-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥238m2021-01-01 → 2021-09-30Cons.Ordinary income
Profit before tax¥673m2022-01-01 → 2022-09-30Cons.Income before income taxes
Profit before tax¥244m2021-01-01 → 2021-09-30Cons.Income before income taxes
Net income (owners)¥467m2022-01-01 → 2022-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥756m2021-01-01 → 2021-12-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥169m2021-01-01 → 2021-09-30Cons.Profit loss attributable to owners of parent
Net income¥467m2022-01-01 → 2022-09-30Cons.Profit loss
Net income¥169m2021-01-01 → 2021-09-30Cons.Profit loss
Total assets¥5.8bnat 2022-09-30Cons.Assets
Total assets¥5.2bnat 2021-12-31Cons.Assets
Total assets¥4.5bnat 2021-09-30Cons.Total assets (5-year summary)
Total liabilities¥604mat 2022-09-30Cons.Liabilities
Total liabilities¥446mat 2021-12-31Cons.Liabilities
Net assets / equity¥5.2bnat 2022-09-30Cons.Net assets
Net assets / equity¥4.8bnat 2021-12-31Cons.Net assets
Net assets / equity¥4.2bnat 2021-09-30Cons.Net assets (5-year summary)
Cash and deposits¥3.6bnat 2022-09-30Cons.Cash and deposits
Cash and deposits¥2.3bnat 2021-12-31Cons.Cash and deposits
Cash & equivalents¥3.4bnat 2022-09-30Cons.Cash and cash equivalents
Cash & equivalents¥2.2bnat 2021-12-31Cons.Cash and cash equivalents
Cash & equivalents¥2.2bnat 2021-09-30Cons.Cash and cash equivalents
Cash & equivalents¥2.1bnat 2020-12-31dCons.Cash and cash equivalents
Operating cash flow¥953m2022-01-01 → 2022-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥366m2021-01-01 → 2021-12-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥562m2021-01-01 → 2021-09-30Cons.Net cash provided by used in operating activities
Investing cash flow¥57m2022-01-01 → 2022-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥279m2021-01-01 → 2021-12-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥487m2021-01-01 → 2021-09-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥11m2022-01-01 → 2022-09-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥16m2021-01-01 → 2021-12-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥7m2021-01-01 → 2021-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥22.282022-01-01 → 2022-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-0.112022-07-01 → 2022-09-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥36.072021-01-01 → 2021-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥8.082021-01-01 → 2021-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-6.372021-07-01 → 2021-09-30dCons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥22.272022-01-01 → 2022-09-30Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥36.042021-01-01 → 2021-12-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥8.072021-01-01 → 2021-09-30Cons.Diluted earnings per share (5-year summary)
Equity ratio89.5%at 2022-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio91.3%at 2021-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio93.2%at 2021-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

All source rows · 449
ItemContextValueUnit
Capital surplusPrior1YearInstant2446703000JPY
Capital surplusCurrentQuarterInstant2455328000JPY
Retained earningsPrior1YearInstant49631000JPY
Retained earningsCurrentQuarterInstant516802000JPY
Treasury stockPrior1YearInstant-21000JPY
Treasury stockCurrentQuarterInstant-21000JPY
Shareholders equityPrior1YearInstant4753234000JPY
Shareholders equityCurrentQuarterInstant5237654000JPY
Valuation difference on available for sale securitiesPrior1YearInstant23919000JPY
Valuation difference on available for sale securitiesCurrentQuarterInstant100000JPY
Valuation and translation adjustmentsPrior1YearInstant23919000JPY
Valuation and translation adjustmentsCurrentQuarterInstant100000JPY
Subscription rights to sharesPrior1YearInstant10850000JPY
Subscription rights to sharesCurrentQuarterInstant8490000JPY
Net assetsPrior1YearInstant4788004000JPY
Net assetsCurrentQuarterInstant5246245000JPY
Liabilities and net assetsPrior1YearInstant5234197000JPY
Liabilities and net assetsCurrentQuarterInstant5849936000JPY
Business revenuePrior1YTDDuration1623136000JPY
Business revenueCurrentYTDDuration1904302000JPY
Cost of business revenue business expensesPrior1YTDDuration268927000JPY
Cost of business revenue business expensesCurrentYTDDuration167984000JPY
Research and development expenses business expensesPrior1YTDDuration780550000JPY
Research and development expenses business expensesCurrentYTDDuration840102000JPY
Other selling general and administrative expenses business expensesPrior1YTDDuration466478000JPY
Other selling general and administrative expenses business expensesCurrentYTDDuration394992000JPY
Business expenses business expensesPrior1YTDDuration1515956000JPY
Business expenses business expensesCurrentYTDDuration1403080000JPY
Operating incomePrior1YTDDuration107179000JPY
Operating incomeCurrentYTDDuration501222000JPY
Interest income noiPrior1YTDDuration1352000JPY
Interest income noiCurrentYTDDuration491000JPY
Interest on securities noiPrior1YTDDuration16154000JPY
Interest on securities noiCurrentYTDDuration11664000JPY
Foreign exchange gains noiPrior1YTDDuration127264000JPY
Foreign exchange gains noiCurrentYTDDuration182461000JPY
Subsidy income noiPrior1YTDDuration5785000JPY
Subsidy income noiCurrentYTDDuration－JPY
Other noiPrior1YTDDuration2817000JPY
Other noiCurrentYTDDuration388000JPY
Non operating incomePrior1YTDDuration153373000JPY
Non operating incomeCurrentYTDDuration195005000JPY
Interest expenses noePrior1YTDDuration905000JPY
Interest expenses noeCurrentYTDDuration4253000JPY
Commitment fee noePrior1YTDDuration－JPY
Commitment fee noeCurrentYTDDuration4083000JPY
Stock issuance cost noePrior1YTDDuration120000JPY
Stock issuance cost noeCurrentYTDDuration287000JPY
Loss on valuation of compound financial instruments noePrior1YTDDuration2820000JPY
Loss on valuation of compound financial instruments noeCurrentYTDDuration4220000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2021-12-31pass
balance sheet identityconsolidated 2022-09-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2021-12-31pass
statement vs summary · net assetsconsolidated 2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2021-01-01/2021-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-01-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2021-01-01/2021-09-30pass
statement vs summary · operating cash flowconsolidated 2022-01-01/2022-09-30pass
statement vs summary · total assetsconsolidated 2021-12-31pass
statement vs summary · total assetsconsolidated 2022-09-30pass